Research Outputs (5)

Sort by: Date | Title

10 | 25 | 50 | 100

1/1

1 A B C D E F G H I K L M N O P Q R S T W Z All

Randomized, Open Label, Phase III Trial of Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (NSCLC)
MOK Shu Kam Tony, JASSEM J., LANGER J. C., KARP D. D., BENNER J. R., GREEN J. S., PARK K., NOVELLO S., STRAUSZ J., GUALBERTO A. ( 2010 )
ASCO Annual Meeting 2010
Refereed conference paper presented and published in conference proceedings
Randomized, Open-Label Phase II Study of Motesanib or Bevacizumab in Combination with Paclitaxel and Carboplatin (P/C) for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
BLUMENSCHEIN R. G., KABBINAVAR F. F., MENON H., MOK Shu Kam Tony, STEPHENSON J., BECK T. J., LAKSHMAIAH K., KRACHT K., SIKORSKI S. R., SCHWARTZBERG S. L. ( 2010 )
ASCO Annual Meeting 2010
Refereed conference paper presented and published in conference proceedings
RANDOMIZED TRIALS IN PATIENTS WITH EGFR MUTATIONS
Mok T ( 2010 )
JOURNAL OF THORACIC ONCOLOGY
Other conference paper
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1
Hong B, Lui VWY, Hui EP, Lu YL, Leung HSY, Wong EYL, Cheng SH, Ng MHL, Mills GB, Chan ATC ( 2010 )
BIOCHEMICAL PHARMACOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.bcp.2009.10.021
Risk of second primary malignancies following nasopharyngeal carcinoma in Hong Kong
Goggins W.B., Yu I.T.S., Tse L.A., Leung S.F., Tung S.Y., Yu K.S. ( 2010 )
Cancer Causes and Control
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1007/s10552-010-9574-x

10 | 25 | 50 | 100

1/1

Research Outputs (5)

Share Link

Our policy towards the use of cookies